BELTRAMELLO JO ANN 4
4 · MOMENTA PHARMACEUTICALS INC · Filed Aug 11, 2020
Insider Transaction Report
Form 4
BELTRAMELLO JO ANN
Chief HR and Inf. Officer
Transactions
- Exercise/Conversion
CommonStock
2020-08-07$18.85/sh+2,690$50,707→ 59,796 total - Sale
Common Stock
2020-08-07$32.00/sh−2,690$86,080→ 58,452 total - Exercise/Conversion
Common Stock
2020-08-07+1,346→ 61,142 total - Sale
Common Stock
2020-08-10$32.36/sh−622$20,128→ 57,830 total - Exercise/Conversion
Stock Option (Right to Buy)
2020-08-07−1,326→ 10,888 totalExercise: $18.85From: 2019-05-07Exp: 2027-02-07→ Common Stock (1,326 underlying) - Exercise/Conversion
Stock Option (Right to Buy)
2020-08-07−1,364→ 21,400 totalExercise: $18.85From: 2018-02-07Exp: 2027-02-07→ Common Stock (1,364 underlying) - Exercise/Conversion
Restricted Stock Units
2020-08-07−1,346→ 2,691 total→ Common Stock (1,346 underlying)
Footnotes (4)
- [F1]This transaction was effected pursuant to a Rule 10b5-1 trading plan.
- [F2]Shares received pursuant to settlement of Restricted Stock Units that were granted on February 7, 2017.
- [F3]Restricted Stock Units convert into common stock on a one-for-one basis.
- [F4]Subject to the officer's continued employment with the company, the restricted stock units will vest with respect to 25% of the shares on the first anniversary of the grant date, and the remainder will vest in equal quarterly installments over the subsequent three years.